Sio Capital Management, LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$355M
Signature - Title
Jin W. Lee - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Sio Capital Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Sio Capital Management, LLC reported 51 stock holdings with total value $355M as of Q4 2024. Top holdings included ICLR, MMS, CI, LH, and SNY.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 51 $355M +$233M -$84.2M +$149M ICLR, MMS, CI, LH, SNY 13F-HR 2/14/2025, 11:00 AM
Q3 2024 38 $223M +$71.6M -$136M -$64.4M LH, TEVA, MMS, ZBH, VXRT 13F-HR 11/14/2024, 02:00 PM
Q2 2024 46 $265M +$168M -$170M -$1.39M LH, TFX, ZBH, SNN, OGN 13F-HR 8/14/2024, 02:00 PM
Q1 2024 44 $282M +$116M -$250M -$134M LH, CI, GMED, MDGL, GSK 13F-HR 5/15/2024, 01:00 PM
Q4 2023 42 $439M +$167M -$141M +$25.4M MRTX, GRCL, LH, CI, GMED 13F-HR 2/13/2024, 02:00 PM
Q3 2023 63 $323M +$151M -$185M -$33.5M LH, GMED, GSK, UTHR, CI 13F-HR 11/14/2023, 02:00 PM
Q2 2023 62 $393M +$267M -$83M +$184M GEHC, SWAV, LH, CI, BCYC 13F-HR 8/14/2023, 04:36 PM
Q1 2023 44 $202M +$104M -$16.9M +$87.6M CNC, CI, BCYC, COR, UTHR 13F-HR 5/12/2023, 04:00 PM
Q4 2022 44 $270M +$99.3M -$43.2M +$56.1M RXDX, MSAC, BCYC, CI, OGN 13F-HR 2/13/2023, 03:00 PM
Q3 2022 49 $315M +$135M -$10M +$125M COR, APLS, GSK, MSAC, RLMD 13F-HR 11/14/2022, 11:49 AM
Q2 2022 61 $266M +$146M -$12M +$134M COR, MSAC, OGN, CI, INGN 13F-HR 8/15/2022, 01:34 PM
Q1 2022 64 $302M +$124M -$57.3M +$67.2M VRTX, MSAC, CI, MRK, SNY 13F-HR 5/16/2022, 02:00 PM
Q4 2021 69 $331M +$133M -$31.2M +$102M CI, MSAC, CRIS, MRK, CAH 13F-HR 2/14/2022, 01:03 PM
Q3 2021 59 $310M +$68.9M -$101M -$32.2M CI, CRIS, GLD, SOLY, UHS 13F-HR 11/15/2021, 03:00 PM
Q2 2021 70 $368M +$72.9M -$166M -$92.9M CRIS, CI, SOLY, GLD, AVAH 13F-HR 8/16/2021, 04:00 PM
Q1 2021 85 $478M +$144M -$157M -$13.6M CRIS, CI, CAH, GLD, SOLY 13F-HR 5/14/2021, 04:00 PM
Q4 2020 89 $489M +$148M -$146M +$1.67M CRIS, CVM, GLD, SPRB, CHRS 13F-HR 2/16/2021, 12:03 PM
Q3 2020 88 $504M +$259M -$28.7M +$231M MESO, GLD, CHRS, MCK, JNJ 13F-HR 11/16/2020, 01:00 PM
Q2 2020 78 $343M +$157M -$98.5M +$58.6M CHRS, GLD, MCK, TEVA, GWPH 13F-HR 8/14/2020, 02:00 PM
Q1 2020 69 $298M +$159M -$56.7M +$103M AMGN, MCK, CHRS, CVM, GWPH 13F-HR 5/15/2020, 03:40 PM
Q4 2019 67 $414M +$207M -$31.1M +$176M ITCI, GWPH, AGN, CHRS, MDT 13F-HR 2/14/2020, 03:00 PM
Q3 2019 61 $309M +$143M -$46M +$97M GWPH, JNJ, AGN, HCA, WCG 13F-HR 11/14/2019, 03:00 PM
Q2 2019 68 $411M +$229M -$41.3M +$188M ACAD, GWPH, HCA, WCG, GSKXXXX 13F-HR 8/14/2019, 04:00 PM
Q1 2019 68 $366M +$194M -$34.8M +$160M CVS, BIIB, GILD, HCA, MDT 13F-HR 5/15/2019, 04:00 PM
Q4 2018 67 $270M +$161M -$19.1M +$142M MDT, SNY, ALNY, COR, CI 13F-HR 2/14/2019, 03:00 PM
Q3 2018 62 $284M +$162M -$23.1M +$139M GSKXXXX, CIXXXX, PCRX, KURA, AET 13F-HR 11/14/2018, 03:00 PM
Q2 2018 49 $181M +$102M -$45.5M +$56.8M KURA, ELV, HCA, MEIPXXXX, ICLR 13F-HR 8/14/2018, 04:02 PM
Q1 2018 31 $166M +$110M -$4.47M +$106M CBIO, SNY, KURA, ELV, BIIB 13F-HR 5/15/2018, 04:00 PM
Q4 2017 45 $177M +$88.9M -$15.2M +$73.7M SAGE, GSKXXXX, AET, ELV, QTNT 13F-HR 2/14/2018, 03:01 PM
Q3 2017 53 $192M +$100M -$34.1M +$66.4M AXGTXXXX, SAGE, QTNT, ADMP, INSM 13F-HR 11/14/2017, 03:00 PM
Q2 2017 58 $210M +$102M -$46.5M +$55.6M QTNT, JNJ, SNY, ISRG, AET 13F-HR 8/14/2017, 04:00 PM
Q1 2017 45 $178M +$109M -$13.1M +$95.7M ACOR, QTNT, SNY, GSKXXXX, PHG 13F-HR 5/15/2017, 04:00 PM
Q4 2016 43 $171M +$113M -$29.5M +$83.9M ACAD, QTNT, SNY, CERN, GSKXXXX 13F-HR 2/14/2017, 03:00 PM
Q3 2016 31 $143M +$54.3M -$28.1M +$26.1M QTNT, AMGN, PHG, CAH, SNY 13F-HR 11/15/2016, 08:38 AM
Q2 2016 42 $195M +$101M -$49.9M +$51.1M QTNT, BIIB, CERN, CAH, ATHN 13F-HR 8/15/2016, 04:31 PM
Q1 2016 42 $273M +$181M -$15M +$166M JAZZ, QTNT, NEOS, MCK, AMGN 13F-HR 5/16/2016, 04:01 PM
Q4 2015 42 $226M +$123M -$14.3M +$108M QTNT, DYAX, SNY, NEOS, MCK 13F-HR 2/16/2016, 03:01 PM
Q3 2015 33 $129M +$73.9M -$7.5M +$66.4M NEOS, JNJ, MDT, CAH, UNH 13F-HR 11/13/2015, 03:15 PM
Q2 2015 39 $202M +$147M -$18.5M +$128M GILD, QTNT, GSKXXXX, RXDX, FLML 13F-HR 8/14/2015, 04:06 PM
Q1 2015 30 $176M +$124M -$12.4M +$111M CELG, QTNT, PFNX, MRK, LLY 13F-HR 5/15/2015, 04:01 PM
Q4 2014 29 $127M QTNT, SNY, GSKXXXX, F113PS, ADMP 13F-HR 2/17/2015, 03:14 PM